Blue Bud

Overview

Blue Bud is a minor cultivar in the sprawling 'blue' family of cannabis strains descended, directly or loosely, from DJ Short's Blueberry lineage ^[1]. It appears in a handful of seed bank catalogs and community databases but has no meaningful presence in peer-reviewed cannabis chemotyping studies, dispensary lab-data aggregations, or cannabis journalism No data.

This article treats Blue Bud the way it should be treated: as a lightly documented commercial name whose properties are described almost entirely by sellers. Where we cite numbers, they come from vendor listings, not independent labs.

Chemistry

Cannabinoids. Vendor listings put Blue Bud's THC in the mid-to-high teens, with negligible CBD Weak / limited. That range is unremarkable for modern hybrids and consistent with the broader Blueberry family, which tends to be THC-dominant with CBD typically under 1% based on large chemotype surveys of commercial cannabis ^[2].

Terpenes. Blue-family cultivars are often reported to be myrcene-dominant, sometimes with notable pinene or caryophyllene, and this is the profile marketers assign to Blue Bud Weak / limited. There is no published terpene analysis specifically for a cultivar sold under the name 'Blue Bud,' and terpene profiles vary substantially across grows even within the same cultivar name ^[3]. Treat any specific terpene percentage on a Blue Bud product page as a claim about that particular batch, not about the strain in general.

A note on the 'sweet blueberry' aroma. The classic Blueberry aroma is not fully explained by any single terpene. It likely involves esters and other volatile compounds that are not part of standard cannabis terpene panels Weak / limited ^[4].

Reported Effects

There are no clinical studies of Blue Bud specifically, and no controlled human trials of any commercial cannabis cultivar's 'effects profile' in the sense that dispensary menus use the term No data. What you'll read on seed sites — 'relaxing body high,' 'euphoric,' 'good for stress' — is folklore aggregated from user reviews.

A few honest generalities:

• Cannabis at 15–20% THC will impair coordination, short-term memory, and reaction time in most users Strong evidence ^[5].
• The popular idea that indica vs. sativa labels predict sedation vs. stimulation is not supported by chemotype data; those labels correlate poorly with measured cannabinoid and terpene content Strong evidence ^[3].
• Individual response to any given cultivar is driven by dose, route of administration, tolerance, set, and setting far more than by strain name Strong evidence ^[5].

If a budtender tells you Blue Bud will do a specific thing to you, they are guessing.

Lineage

Blue Bud's parentage is disputed and poorly documented Disputed. Different vendor listings variously describe it as a Blueberry phenotype, a Blueberry × unknown indica cross, or an unrelated hybrid that simply borrowed the 'blue' naming convention.

This is common in the 'blue' family. DJ Short's original Blueberry, developed in the 1970s–80s from Afghani, Thai, and Purple Thai genetics, has been extensively hybridized, backcrossed, and renamed by other breeders, and genetic studies have shown that strain names in the commercial market frequently do not reflect actual genetic relationships ^[6]. Two plants sold as 'Blue Bud' from different sources may not be closely related.

Unless you buy from a breeder who publishes a verifiable pedigree, treat Blue Bud's lineage as unknown.

Cultivation Basics

Based on vendor descriptions and general Blueberry-family behavior:

• Flowering time: roughly 8–9 weeks indoors Weak / limited.
• Structure: short-to-medium, bushy, with dense flowers — typical of indica-leaning hybrids Weak / limited.
• Yield: vendor-reported ~400–500 g/m² indoors under competent conditions Weak / limited. Real-world yields depend far more on light intensity, training, and environment than on genetics Strong evidence.
• Environment: blue-family plants often show purple coloration in cooler night temperatures, driven by anthocyanin expression Strong evidence ^[7]. Cooler finishes may enhance color but do not necessarily improve potency.
• Difficulty: moderate; nothing about the reported phenotype suggests unusual sensitivity, but without a verified breeder line, seed-to-seed variation may be high.

Marketing vs. Reality

A few claims commonly attached to Blue Bud (and blue-family strains generally) deserve pushback:

• 'Indica-dominant, so it'll sedate you.' Indica/sativa labels are unreliable predictors of effect Strong evidence ^[3].
• 'Myrcene above 0.5% makes it a couch-lock strain.' This threshold is folklore. It appears in blogs and budtender training decks, not in the scientific literature No data.
• 'It's a true Blueberry descendant.' Sometimes true, sometimes not. Genetic testing of commercial strain names routinely finds inconsistencies between labeled lineage and actual genetics ^[6].
• 'Great for anxiety/pain/sleep.' No cultivar-specific evidence exists. General cannabis evidence for these indications is mixed and dose-dependent Weak / limited ^[5].

Blue Bud is a fine name for a plant. It is not a diagnosis, a prescription, or a guarantee.

Sources

How this page was made

Related

• Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...